Tracleer (bosentan) is an oral endothelin receptor antagonist from Janssen-Cilag and Actelion for pulmonary arterial hypertension, supplied as 62.5 mg and 125 mg film-coated tablets and a 32 mg dispersible tablet, and it is used under monthly liver tests and pregnancy risk-minimisation.
M Care Exports supplies Tracleer (bosentan) and Indian-made bosentan tablets to hospital pharmacies, licensed importers and tender authorities internationally, with established supply lanes into the GCC, Africa and Europe. If you are looking for bosentan 62.5 mg or 125 mg tablets, send the destination, the strength, the pack and the quantity, and we quote per destination, subject to the registration route and import licence your regulator requires.
Also marketed as Stayveer.
Bosentan exporter and bulk supplier from India.
"We need a partner for bosentan" is a typical enquiry from a pulmonary hypertension centre or a hospital tender desk. M Care is a merchant-exporter: we supply originator or regulator-registered brands and Indian-made lines, and we confirm which one your destination's route accepts before quoting. The EU SmPC names Janssen-Cilag International NV as the Tracleer marketing authorisation holder, and the EMA also lists Stayveer, which it describes as the same medicine as Tracleer, authorised through informed consent. In the US, Actelion Pharmaceuticals US, Inc. is the labeler of Tracleer on DailyMed, and DailyMed also lists bosentan labels from other labelers, including tablets for suspension. Indian-made lines on our roster include Bosenat 62.5 mg, Bosentas 62.5 mg and 125 mg, and Lupibose 62.5 mg tablets. We do not state that any Indian-made line is registered in a given destination. The labels we read give room-temperature storage (20 to 25 °C in the US; do not store the blisters above 25 °C in the EU), so the shipment does not need a cold chain. Related lines that buyers list beside it are macitentan and the other pulmonary hypertension products on our cardiovascular hub.
Source
WHO-GMP-certified Indian manufacturing line, named on every quote.
Minimum order
No blanket MOQ. Set by the source manufacturer's minimum batch-release quantity for the strength and pack ordered.
Pricing
On request. Indicative FOB or CIF quote, formal proforma on confirmation.
Incoterms
EXW, FOB, CIF, CIP or DAP.
Payment
Letter of credit (sight or usance) and telegraphic transfer.
Documentation
WHO-GMP certificate of the source line, product-specific CoPP, batch CoA, method of analysis, Free Sale Certificate, Certificate of Origin, CTD or eCTD dossier. On request.
Shelf-life
Minimum remaining shelf-life agreed per order and confirmed on the proforma.
Response
Availability and CoPP status within two working days; pre-alert documents before dispatch.
Dual endothelin receptor antagonist, sourced and documented for export.
Bosentan is a dual endothelin receptor antagonist, as the EU SmPC describes it, taken by mouth twice daily. The US label (Actelion Pharmaceuticals US, Inc., DailyMed page updated 17 November 2025) lists adults with WHO Group 1 pulmonary arterial hypertension (PAH), to improve exercise ability and decrease clinical worsening, and paediatric patients aged 3 years and older with idiopathic or congenital PAH, to improve pulmonary vascular resistance. It lists 62.5 mg and 125 mg film-coated tablets and a 32 mg tablet for oral suspension. The EMA page lists Tracleer for PAH to improve exercise capacity and symptoms in patients with WHO functional class III, with some improvements also shown in class II, and to reduce the number of new digital ulcers in patients with systemic sclerosis and ongoing digital ulcer disease. The EMA product number is EMEA/H/C/000401, and the SmPC gives 15 May 2002 as the date of first authorisation, with Janssen-Cilag International NV as holder. The EU SmPC covers 62.5 mg and 125 mg film-coated tablets and a 32 mg dispersible tablet. The UK emc lists bosentan 62.5 mg film-coated tablets from Viatris for the same two indications. The US label adds that doses above 125 mg twice daily did not appear to confer additional benefit sufficient to offset the increased risk of hepatotoxicity.
Active ingredient
Bosentan (as monohydrate). Dual endothelin receptor antagonist.
Forms and strengths
62.5 mg film-coated tablet; 125 mg film-coated tablet; 32 mg dispersible tablet (tablet for oral suspension).
Indications
Bosentan is an oral dual endothelin receptor antagonist used for pulmonary arterial hypertension and, in the EU and UK labels, to reduce new digital ulcers in systemic sclerosis, under monthly liver tests and pregnancy risk-minimisation.
Administration
Oral. Film-coated tablet; dispersible tablet (tablet for oral suspension).
Documentation
Batch-specific CoA, CoPP, manufacturing-site WHO-GMP certificate and stability data compiled per consignment, in the format the destination regulator expects.
Hospital pharmacies, licensed importers and tender desks across our export markets.
India is our origin. We do not sell into the Indian market.
Buyers are hospital pharmacists in pulmonary hypertension and cardiology units, MoH and hospital tender desks, and licensed importers and distributors internationally. Typical enquiries read "I'm looking for Tracleer 62.5 mg for a PAH centre" or "We need a partner for bosentan 125 mg for a tender". Each destination has its own route to registration or import, for example the Emirates Drug Establishment (EDE) in the UAE, NAFDAC in Nigeria and the MHRA in the UK, and we align the offer with it before quoting. Bosentan is used in pulmonary arterial hypertension and, per the EU SmPC, treatment should only be initiated and monitored by a physician experienced in the treatment of PAH, so whether a destination buys a registered product or needs a named-patient or unlicensed import depends on the destination regulator, and M Care Exports confirms the route per enquiry. M Care supplies both originator or regulator-registered brands and Indian-made lines.
GCC registration routes
Supply against MoH registration held by your local licensed importer, or via the GCC central registration pathway.
UK unlicensed routes
Where no UK licence exists, the MHRA Specials and named-patient import routes cover clinically justified demand.
Tender desks
Bid-pack documentation assembled to the tender's specification, from CoPP to batch records.
Dossier support
CTD documentation from the sourcing manufacturer, compiled for your regulator's format.
What the dispensing pharmacist checks on bosentan.
Plan the supply around the monitoring, because it is part of the label. The US boxed warning says to measure liver aminotransferases prior to initiation of treatment and then monthly, and that Tracleer is available only through a restricted distribution programme called the Bosentan REMS. The EU SmPC also requires aminotransferase tests before treatment and at monthly intervals, plus 2 weeks after any dose increase. For pregnancy, the US label contraindicates use in pregnancy, requires pregnancy to be excluded before starting and effective contraception before, during and for one month after treatment. The EU SmPC recommends monthly pregnancy tests and says hormonal contraceptives cannot be the sole method of contraception. The EU SmPC starts adults at 62.5 mg twice daily for 4 weeks, then 125 mg twice daily; the US label ties the maintenance step to age and weight. The US label contraindicates cyclosporine A and glyburide. The EU pack includes a Patient Alert Card. Storage is 20 to 25 °C in the US, with excursions to 15 to 30 °C permitted. The EU SmPC says do not store the blisters above 25 °C, while the white bottles need no special storage conditions. The US label says divided dispersible tablets are stored under the same conditions and used within 7 days.
The documentation pack a regulator actually asks for.
Bosentan tablets need no cold chain on the labels we read. The US label gives 20 to 25 °C with excursions to 15 to 30 °C permitted. The EU Tracleer SmPC says do not store PVC/PE/PVDC/aluminium blisters above 25 °C, says the white high-density polyethylene bottles need no special storage conditions, and asks that bottles be used within 30 days of first opening. The UK emc SmPC for bosentan 62.5 mg from Viatris states no special storage conditions. The EMA also lists Stayveer, authorised on 24 June 2013, as the same medicine as Tracleer. DailyMed lists bosentan labels from Zydus, Actavis, Sun and Lupin alongside Tracleer, and the UK emc lists bosentan film-coated tablets from Viatris, Cipla and Milpharm (Aurobindo). Because of the liver and pregnancy requirements, a destination may attach conditions to import, and we confirm them per enquiry. M Care documentation covers batch certificates of analysis, export documents and destination-aligned dossier support where the regulator asks for it. We state the source and status of each line before quoting, and make no manufacturing or WHO claim for M Care itself.
CoA and MoA, per batch
Batch-specific certificate and method of analysis from the sourcing manufacturer's QC release.
CoPP, WHO-GMP, MFG licence
Certificate of pharmaceutical product, site GMP certificate and manufacturing licence, issued by the state drug regulator and naming the actual manufacturing site.
CTD Module 3
Chemistry, manufacturing and controls documentation available from the sourcing manufacturer for registration filings.
Pack insert, labels, artwork
Destination-language patient information and labelling to the local regulator's standard, locked before shipment.
Pharmacovigilance
A named PV contact arranged in the destination market where the registration requires one.
Adjacent lines procurement desks order alongside bosentan.
Macitentan (Opsumit)
Another endothelin receptor antagonist for pulmonary arterial hypertension.
Ambrisentan
Another endothelin receptor antagonist for pulmonary arterial hypertension.
Adempas (riociguat)
A soluble guanylate cyclase stimulator for pulmonary hypertension.
All cardiovascular
The full category listing for procurement desks.
Molecule · strength · volume · destination. One working day to a quote.
- Send us the specifics. Form and strength, pack preference, destination market and indicative volume for bosentan.
- We route to the right line. The enquiry goes to the WHO-GMP certified manufacturing partner whose certificates fit your regulator.
- Commercial and regulatory offer. FOB or CIF price with the documentation list, named manufacturing site and current certificate validity.
- Order, produce, release, ship. QC release on the Indian side, batch documents compiled, despatch on the agreed incoterm.
- After delivery. Batch records and certificates archived and retrievable for the life of the product on your shelf.
Bosentan supply, the specific questions.
What sets the landed price of Tracleer for an importer?
We do not publish prices. The landed cost depends on whether you want originator Tracleer, a regulator-registered bosentan or an Indian-made line, the strength (62.5 mg, 125 mg or the 32 mg dispersible tablet), the pack size, the quantity, the registration route in your destination and Incoterms. No cold chain applies on the labels we read. M Care Exports quotes per destination once we have the strength, pack and quantity.
Is there a Tracleer generic?
Regulators list bosentan under other names. DailyMed lists bosentan labels from Zydus, Actavis, Sun and Lupin, including tablets for suspension, alongside the Actelion Tracleer label. In the UK, the emc lists bosentan film-coated tablets from Viatris, Cipla and Milpharm. In the EU the EMA lists Stayveer, which it describes as the same medicine as Tracleer; the company that makes Tracleer agreed that its scientific data could be used for it (informed consent). Which of these your destination accepts depends on its registration route, and we confirm that per enquiry.
What is Tracleer used for, and what is the bosentan indication?
The EMA lists Tracleer for pulmonary arterial hypertension to improve exercise capacity and symptoms in patients with WHO functional class III, with some improvements also shown in class II, and to reduce the number of new digital ulcers in patients with systemic sclerosis and ongoing digital ulcer disease. The US label lists adults with WHO Group 1 PAH and paediatric patients aged 3 years and older with idiopathic or congenital PAH. Indications differ by destination labelling, so confirm the local text.
What liver and pregnancy checks does bosentan need?
The US boxed warning says to measure liver aminotransferases prior to initiation of treatment and then monthly, and to exclude pregnancy before the start of treatment. The US label contraindicates pregnancy and requires effective contraception before, during and for one month after treatment. The EU SmPC requires liver tests before treatment, monthly and 2 weeks after any dose increase, and recommends monthly pregnancy tests. These are prescriber duties, and the destination's approved leaflet governs.
I'm looking for Tracleer 62.5 mg and 125 mg. Which presentations exist?
The US and EU labels list 62.5 mg and 125 mg film-coated tablets. Both also list a 32 mg dispersible tablet, called a tablet for oral suspension in the US. The UK emc lists bosentan 62.5 mg from Viatris in blister packs and notes that not all pack sizes may be marketed. Availability depends on the market and the supply line. Send us the destination, strength and pack count and we confirm what we can quote.
Can you supply bosentan to the UAE or Nigeria?
M Care Exports supplies bosentan internationally, as originator or regulator-registered brands or as Indian-made lines such as Bosenat, Bosentas and Lupibose. UAE product registration sits with the Emirates Drug Establishment (EDE), and Nigeria's route runs through NAFDAC, so we confirm which brand and strength your registration or import route accepts before we quote. Send the strength, the brand you need and the quantity.
Who stands behind this page, and where its statements come from.
Reviewed by Dr. Rajat Bhatt, PharmD, Managing Director, M Care Exports. Last reviewed 2026-11-15.
This page is sourcing information for licensed importers, hospital procurement and tender desks. It is not medical, pharmaceutical or prescribing advice, and it is not a substitute for the approved product information of the line on your order. See our full disclaimer.
Send the specifics. You'll have a price inside one working day.
Form and strength, destination market and indicative volume. The Mumbai desk replies within one working day, including when the honest answer is that the route is not viable yet.
